The Global Amniotic Membrane Market is a rapidly growing segment owing to its wide applications in wound care treatment and surgical procedures. Amniotic membrane refers to the innermost layer of the placenta which has anti-inflammatory, anti-scarring and anti-angiogenic properties making it an ideal biological material for wound healing. It acts as a temporary cover for damaged tissues until it regenerates with own cells. As amniotic membrane when used on wounds helps in faster re-epithelialization with reduced inflammation and scarring, its demand is increasing across hospitals and burn centers for treatment of venous ulcers, pressure ulcers, diabetic foot ulcers and surgical or trauma wounds. Owing to properties like rapid re-epithelialization and low cost of treatment compared to other substitutes, amniotic membrane products are becoming first line therapy for wound care management.
The global amniotic membrane market is estimated to be valued at US$ 5.12 billion in 2024 and is expected to exhibit a CAGR of 13% over the forecast period of 2024-2031.
Key Takeaways
Key players operating in the Amniotic Membrane Market are Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical.
Market Trends
Increasing Adoption of Micronized Amniotic Membranes: Micronization of amniotic membranes yields amniotic membrane particles sized 500 microns or less which have enhanced therapeutic properties. Being easier to handle in fluid form, micronized amniotic membranes are gaining popularity over intact membranes sheets in wound management.
Rise of Amnion-Chorion Composite Products: Combining amnion and chorion layers of placental membranes maximizes their benefits. Compared to single layer amnion products, amnion-chorion composites have superior mechanical strength and tissue remodeling capabilities spurring their adoption.
Market Opportunities
Ophthalmology Applications: Amniotic membranes are promising biomaterials for ocular surface reconstruction in conditions like corneal ulcers and reconstructive surgeries due to anti-angiogenic and anti-scarring properties. Their potential to treat ocular disorders is an emerging opportunity.
Cellular Therapy: Incorporating amniotic membrane-derived cells like mesenchymal stem cells can enhance wound healing efficacy. Combining cellular components with amniotic membranes opens possibilities for advanced regenerative therapies.
Considering the impact of the ongoing pandemic, market players need to focus on ensuring steady supply chains, optimizing production capacities, enhancing R&D for new applications, and expanding into high growth regions. Telemedicine and e-commerce platforms can also be leveraged to sustain business operations and meet the rising demand from healthcare practitioners and consumers in the long run.
North America Amniotic Membrane Market
North America currently dominates the global amniotic membrane market, accounting for over 35% of the total market value. Being an economically advanced region with a high adoption rate of advanced therapies, the U.S. is the major revenue contributor. Factors such as the presence of key industry players, rising prevalence of ocular disorders, favorable reimbursement policies, and growing awareness about amniotic membrane-based treatments are fueling market growth in the region.
